πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 650 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7179815

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7176211

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7173005

Insulin and IGF-1 receptor agonists and antagonists

ANTYRA INC. Β· Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7163934

Methods for treating delirium glucocorticoid receptor-specific antagonists

Corcept Therapeutics Incorporated Β· Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7151115

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7150871

Treatment of acute lung injury, fibrosis and metastasis with antagonists of Ξ±vΞ²6

The Regents of the University of California Β· Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7115560

Methods for modulating gastric secretion using prokineticin receptor antagonists

The Regents of the University of California Β· Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7105488

G protein-coupled receptor antagonists

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7081459

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jul 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7071200

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7071224

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7064112

Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Jun 20 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7056500

Polymer conjugates of opioid antagonists

Nektar Therapeutics AL, Corporation Β· Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7056927

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7037916

Pyrimidine derivatives as IL-8 receptor antagonists

Pharmacopeia Drug Discovery, Inc. Β· Granted Tue May 02 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7015226

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Mar 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6964953

Methods for treating stress disorders using glucocorticoid receptor-specific antagonists

Corcept Therapeutics Incorporated Β· Granted Tue Nov 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6953779

Melanocortin receptor antagonists and modulations of melanocortin receptor activity

The Regents of the University of California Β· Granted Tue Oct 11 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6951858

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Oct 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6939883

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Sep 06 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6930185

Melanin-concentrating hormone antagonist

Takeda Chemical Industries Ltd. Β· Granted Tue Aug 16 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6921761

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jul 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6919347

Bradykinin B1 receptor antagonists

Pharmacopeia Drug Discovery, Inc. Β· Granted Tue Jul 19 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6903131

3,4-di-substituted maleimide compounds as CXC chemokine receptor antagonists

Pharmacopeia Drug Discovery, Inc. Β· Granted Tue Jun 07 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired